Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average.
Left:
||||
Free cash flow yield
Latest
7.69%
↑ 157% above average
Average (9y)
-13.41%
Historical baseline
Range
High:7.69%
Low:-33.51%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 7.69% | +241.3% |
| 2023 | -5.44% | +73.3% |
| 2022 | -20.36% | -196.0% |
| 2021 | -6.88% | +34.6% |
| 2020 | -10.52% | +54.8% |
| 2019 | -23.28% | +30.5% |
| 2018 | -33.51% | -3946.6% |
| 2017 | 0.87% | +104.1% |
| 2016 | -21.23% | +1.1% |
| 2015 | -21.47% | - |